Naumann Discusses Notable Research Efforts in Endometrial Cancer

Welcome to OncLive On Air^®! I’m your host today, Ashling Wahner.

OncLive On Air^® is a podcast from OncLive^®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive^® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, sponsored by GSK, we had the pleasure of speaking with R. Wendel Naumann, MD, about research updates in endometrial cancer. Dr Naumann is a gynecologic oncologist at Atrium Health Levine Cancer Institute in Charlotte, North Carolina.

In our exclusive interview, Dr Naumann discussed the role of frontline maintenance therapy for patients with endometrial cancer; which patients are likely to benefit from the phase 3 RUBY (NCT03981796) and NRG-GY018 trial (NCT03914612) regimens; and ongoing research that may elucidate optimal treatments for patients with recurrent, mismatch repair–deficient disease.

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air^®, sponsored by GSK. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive^® is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air^®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air^®.

*OncLive On Air^® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.